PML risk and natalizumab: more questions than answers

Title
PML risk and natalizumab: more questions than answers
Authors
Keywords
-
Journal
LANCET NEUROLOGY
Volume 9, Issue 3, Pages 231-233
Publisher
Elsevier BV
Online
2010-01-30
DOI
10.1016/s1474-4422(10)70025-9

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started